Zeo ScientifiX, Inc. (ZEOX) Form 8-K — Oct 26, 2026
Zeo ScientifiX (OTCQB: ZEOX) announced a definitive strategic partnership agreement with Nasdaq-listed Pluri Inc. (PLUR) to expand their U.S. manufacturing and commercialization platform in regenerative medicine, aesthetics, wellness, and longevity. ZEO will initially issue shares representing 50% of its issued and outstanding common stock to Pluri, which will own 50% of ZEO at closing, expected in Q4 2026.
Key figures
- Pluri patents
- over 200 patents
- Equity issued percent
- 50% of issued and outstanding common stock
- Pluri ownership post closing
- 50% of ZEO
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.